Literature DB >> 9433383

Myeloid leukemia and myelodysplastic syndrome relapsing as granulocytic sarcoma (chloroma) after allogeneic bone marrow transplantation.

A Szomor1, J R Passweg, A Tichelli, T Hoffmann, B Speck, A Gratwohl.   

Abstract

Of 229 consecutive patients receiving allogeneic blood or bone marrow stem cell transplants for acute myeloid leukemia, chronic myeloid leukemia, or myelodysplastic syndrome between 1974 and 1996, 52 patients relapsed. The original tumor recurred as granulocytic sarcoma (chloroma) in three patients (1.3%). Chloroma was found in the ovary in two patients and in the central nervous system in one patient. None of these three patients had experienced > or = grade II acute or more than limited chronic graft-versus-host disease. The intervals between transplantation and recurrence with chloroma were 2, 6, and 13 years. Two patients received a second transplant, and all three died of treatment sequelae.

Entities:  

Mesh:

Year:  1997        PMID: 9433383     DOI: 10.1007/s002770050350

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  15 in total

Review 1.  Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome.

Authors:  William B Clark; Stephen A Strickland; A John Barrett; Bipin N Savani
Journal:  Haematologica       Date:  2010-06       Impact factor: 9.941

Review 2.  Granulocytic sarcoma: a systematic review.

Authors:  Asu Fergun Yilmaz; Guray Saydam; Fahri Sahin; Yusuf Baran
Journal:  Am J Blood Res       Date:  2013-12-18

3.  Radiation therapy for chloroma (granulocytic sarcoma).

Authors:  Richard Bakst; Suzanne Wolden; Joachim Yahalom
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-09-28       Impact factor: 7.038

4.  Intraparenchymal myeloid sarcoma and subsequent spinal myeloid sarcoma for acute myeloblastic leukemia.

Authors:  Ki Seong Eom; Tae Young Kim
Journal:  J Korean Neurosurg Soc       Date:  2011-03-31

5.  Granulocytic sarcoma of the temporal bone.

Authors:  B Lee; G M Fatterpekar; William Kim; Peter M Som
Journal:  AJNR Am J Neuroradiol       Date:  2002-10       Impact factor: 3.825

Review 6.  Relapse after allogeneic stem cell transplantation.

Authors:  A John Barrett; Minoo Battiwalla
Journal:  Expert Rev Hematol       Date:  2010-08       Impact factor: 2.929

Review 7.  Isolated extramedullary relapse in the breast of a patient with acute myeloid leukemia following allogeneic stem cell transplantation: case report and review of the literature.

Authors:  Abderrahman Abdelkefi; Lamia Torjman; Saloua Ladeb; Zeineb Sghaïer; Ramzi Jeddi; Amel Lakhal; Amr Ramzu; Amor Gamoudi; Tarek Ben Othman
Journal:  Int J Hematol       Date:  2007-02       Impact factor: 2.490

8.  Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes.

Authors:  Andrew C Harris; Carrie L Kitko; Daniel R Couriel; Thomas M Braun; Sung W Choi; John Magenau; Shin Mineishi; Attaphol Pawarode; Gregory Yanik; John E Levine
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

9.  Recurrent neurotropic chloroma: report of a case and review of the literature.

Authors:  Richard Bakst; Ann Jakubowski; Joachim Yahalom
Journal:  Adv Hematol       Date:  2010-12-01

10.  Myeloid sarcoma: current approach and therapeutic options.

Authors:  Batia Avni; Maya Koren-Michowitz
Journal:  Ther Adv Hematol       Date:  2011-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.